01437nam 2200385Ia 450 991070077820332120110708170351.0(CKB)5470000002411222(OCoLC)740082639(EXLCZ)99547000000241122220110708d1994 ua 0engurbn|||||||||txtrdacontentcrdamediacrrdacarrierIssues associated with use of strontium-89 and other beta emitting radiopharmaceuticals[electronic resource]Washington, DC :U.S. Nuclear Regulatory Commission, Office of Nuclear Material Safety and Safeguards,[1994]1 online resourceNRC information notice ;94-70Title from HTML title screen (viewed on July 8, 2011)."September 29, 1994."StrontiumPhysiological effectRadiopharmaceuticalsBeta raysPhysiological effectStrontiumPhysiological effect.Radiopharmaceuticals.Beta raysPhysiological effect.U.S. Nuclear Regulatory Commission.Office of Nuclear Material Safety and Safeguards.GPOGPOBOOK9910700778203321Issues associated with use of strontium-89 and other beta emitting radiopharmaceuticals3217412UNINA